Pliant Therapeutics (PLRX) Gains from Investment Securities (2019 - 2026)
Pliant Therapeutics (PLRX) reported Gains from Investment Securities of -$323000.0 for Q1 2026, down 3937.5% year-over-year from $8416.9 in Q1 2025, and down 4137.5% quarter-over-quarter from $8000.0 in Q2 2025.
Pliant Therapeutics (PLRX) Gains from Investment Securities (2019 - 2026) Analysis & Trends
Pliant Therapeutics (PLRX) has 7 years of Gains from Investment Securities data on file, last reported at -$323000.0 in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at -$323000.0, down 3937.5% year-over-year; the trailing twelve-month figure through Mar 2026 was -$315000.0 (up 98.67% YoY), and the FY2024 annual result was $43000.0, changed N/A from the prior year.
- Gains from Investment Securities declined to -$323000.0 in Q1 2026 per PLRX's latest filing, from $8000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $23.7 million in Q1 2024 and troughed at -$29.7 million in Q4 2024.
- A 4-year average of -$46000.0 and a median of $0.0 in 2025 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2025 and 2026: Gains from Investment Securities slumped 99.87% in 2025, then tumbled 3937.5% in 2026.
- A 4-year view of Gains from Investment Securities shows it stood at -$1.2 million in 2022, then plunged by 2483.49% to -$29.7 million in 2024, then jumped by 100.03% to $8000.0 in 2025, then sank by 4137.5% to -$323000.0 in 2026.
- Business Quant data shows PLRX's Gains from Investment Securities at -$323000.0 in Q1 2026, $8000.0 in Q2 2025, and -$8000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Pliant Therapeutics | 74.16 Mn | 74.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -323,000.00 |
| Mar 31, 2026 | -323,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Dec 31, 2024 | -29.74 Mn |
| Dec 31, 2024 | -29.74 Mn |
| Jun 30, 2024 | 6.10 Mn |
| Jun 30, 2024 | 6.10 Mn |
| Mar 31, 2024 | 23.70 Mn |
| Mar 31, 2024 | 23.70 Mn |
| Dec 31, 2022 | -1.15 Mn |
| Dec 31, 2022 | -1.15 Mn |
| Sep 30, 2022 | 950,000.00 |
| Sep 30, 2022 | 950,000.00 |
| Jun 30, 2022 | 207,000.00 |
| Jun 30, 2022 | 207,000.00 |
| Mar 31, 2022 | -207,000.00 |
| Mar 31, 2022 | -207,000.00 |